Brooks Laboratories Ltd IPO


Company Name

Opens

Closes

Price Rs

Issue Size


Aug 16, 2011

Aug 18, 2011

90.0 - 100.0

Rs 63.0 Cr.
Brooks Laboratories Ltd is in the business of Pharmaceutical Contract Research & Manufacturing. Brooks Lab manufactures wide range of products catering to critical care segment in Parental Section like Beta Lactam, Cephalosporin & General Dry powder Injectables, Ampoules and Liquid vials, Dry Syrups and Tablets etc.

Brooks Labs has manufacturing unit at Baddi, Himachal Pradesh. Brooks Lab has a world class team to develop new molecules in injectables and clavulanic acid based products supported by sophisticated infrastructure for Research & Development. Brooks Labs is WHO-GMP and ISO 9000-2008 certified company.

Objectives of Brooks Labs IPO
1) To set up our new manufacturing unit at JB SEZ Pvt Ltd, Panoli, Gujarat for manufacturing of various pharmaceuticals formulations;
2) To meet Long Term Working Capital requirement;
3) To meet General Corporate Purpose and;
4) To meet Issue Expenses and Listing of Shares on Stock Exchanges.

ICRA has assigned an IPO Grade 2(Below Average Fundamentals) to
Brooks Laboratories IPO

Public issue of [*] equity shares of face value Rs. 10 each (The "Equity Shares") of Brooks Laboratories Limited ("The Company" or The "Issuer") for cash at a price of Rs. [*] per equity share (including a share premium of Rs. [*] per equity share) aggregating to up to Rs. 63.00 crores (The "Issue"). The issue comprises a net issue of up to [*] equity shares (The "Net Issue"). The issue will constitute [*]% of the fully diluted post issue paid-up capital of the company.

Price band: Rs. 90 to Rs. 100 per equity share of face value of Rs. 10 each

The issue price is 9 times the face value at the lower end of the price band and 10 times the face value at the higher end of the price band.

For our analysis of Brooks Laboratories IPO, visit VJonDalalStreet's New IPOs

New IPOs || Old IPOs || IPO Allotment Status || IPO Basis of Allotment || Grey Market Premiums || IPO Draft Prospectus || IPO News || New IPO Listings



0 comments: